戒烟3:戒烟中的烟碱部分激动剂——伐尼克兰和胱氨酸

Primary Care Cardiovascular Journal (pccj) Pub Date : 2009-04-01 DOI:10.3132/PCCJ.2009.019

P. Aveyard, A. Parsons, R. Begh

{"title":"戒烟3:戒烟中的烟碱部分激动剂——伐尼克兰和胱氨酸","authors":"P. Aveyard, A. Parsons, R. Begh","doi":"10.3132/PCCJ.2009.019","DOIUrl":null,"url":null,"abstract":"Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic partial agonists, including cytisine, which is not yet available in this country, and varenicline, which is.","PeriodicalId":308856,"journal":{"name":"Primary Care Cardiovascular Journal (pccj)","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2009-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine\",\"authors\":\"P. Aveyard, A. Parsons, R. Begh\",\"doi\":\"10.3132/PCCJ.2009.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic partial agonists, including cytisine, which is not yet available in this country, and varenicline, which is.\",\"PeriodicalId\":308856,\"journal\":{\"name\":\"Primary Care Cardiovascular Journal (pccj)\",\"volume\":\"80 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primary Care Cardiovascular Journal (pccj)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3132/PCCJ.2009.019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Cardiovascular Journal (pccj)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3132/PCCJ.2009.019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在英国，吸烟是导致疾病、死亡和医疗费用过高的最可预防的原因。大多数吸烟者都想戒烟，并打算在某个时候戒烟。在我们关于初级保健戒烟系列的第三篇文章中，我们研究了使用尼古丁部分激动剂的证据，包括胱氨酸，它在这个国家还没有上市，还有伐尼克兰。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine

Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic partial agonists, including cytisine, which is not yet available in this country, and varenicline, which is.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Primary Care Cardiovascular Journal (pccj)

自引率

0.00%

发文量